PACIFIC Study in Unresectable NSCLC

PACIFIC Study in Unresectable NSCLC

User Photo
obr

1 year
173 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Kristin Higgins, MD, Associate Professor, Department of Radiation ONcology, Winship Cancer Institute of Emory University Medical Director, The Emory Clinic provides her interpretation of the data presented at ASCO 2019 from the PACIFIC Study investigating durvalumab in stage 3 unresectable non-small cell lung cancer (NSCLC).
Up Next Autoplay
>